IASLC WCLC 2018

Q: 귀하의 국가에서 사용할 수 없는 경우 IASLC WCLC 2018를 다운로드하는 방법은 무엇입니까?

제한된 국가 또는 지역에서 IASLC WCLC 2018를 다운로드하는 방법을 알아보려면 <a href="https://apkpure.com/howto/how-to-download-an-iphone-app-if-it-is-not-available-in-your-country">여기</a>를 클릭하십시오.

Q: IASLC WCLC 2018를 실행하기 위한 최소 요구 사항은 무엇입니까?

IASLC WCLC 2018의 최소 요구 사항을 보려면 다음 목록을 확인하십시오.<br/><ul><li>iPhone-</li><li>iPad-</li></ul>

Free

5.0.0for iPhone, iPad

Webges Meeting Applications

Developer

Sep 14, 2018

Update Date

Education

Category

APKPure

Age Rating

Apps in this category do not contain restricted content.

Apps in this category may contain mild or occasional cartoon, fantasy or real-life violence, as well as occasional or mild adult, sexually suggestive or horrifying content and may not be suitable for children under 9 years of age.

12+

Apps in this category may contain occasional mild indecent language, frequent or intense cartoon or real-life violence, minor or occasional adult or sexually suggestive material, and simulated gambling, and may be for children under 12 years of age.

17+

You must be at least 17 years old to access this App.

Apps in this category may contain frequent and intense offensive language; Frequent and intense cartoon, fantasy or realistic violence: frequent and intense adult, scary and sexually suggestive subjects: as well as sexual content, nudity, tobacco, alcohol and drugs, may not be suitable for children under 17 years of age.

IASLC WCLC 2018 스크린 샷

iPad

iPhone

About IASLC WCLC 2018

The IASLC 19th World Conference on Lung Cancer (WCLC 2018) is the premier international gathering of physicians and researchers in the field of lung cancer and thoracic malignancies. The Conference motto “Take Action Against Lung Cancer” captures the collaborative spirit of the Conference which will be both a scientific and educational event.

Medical doctors, scientists, nurses, health professionals, government officials, partners from the industry, health advocacy groups and patients will come together in order to obtain and exchange information on advances in the management of lung cancer and other thoracic malignancies, while considering both global and regional aspects.